Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/16051813

Download in:

View as

General Info

PMID
16051813